Form 4: TransDigm Group Executive Joel Reiss Executes Stock Option and Sells Shares

TransDigm Group's Co-Chief Operating Officer, Joel Reiss, exercised stock options and sold shares on January 21, 2025, according to a recent SEC filing.

Summary

• Joel Reiss, Co-Chief Operating Officer of TransDigm Group, exercised stock options to acquire 3,000 shares of common stock at a price of $226.34 per share on January 21, 2025.
• On the same day, Mr. Reiss sold a total of 3,000 shares of common stock in multiple transactions at prices ranging from $1,352.68 to $1,363.83.
• The sales were executed in multiple tranches with varying prices, with the weighted average prices disclosed for each tranche.
• Following these transactions, Mr. Reiss directly owns 3,600 shares of TransDigm common stock and 9,300 stock options.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions by an executive, with no indication of positive or negative sentiment.

Industry Context

This is a routine filing related to executive stock transactions and is common for publicly traded companies. It provides transparency into the trading activities of company insiders.

Comparison to Industry Standards

• Executive stock option exercises and sales are a common practice across publicly listed companies.
• The reporting requirements of SEC Form 4 are standard for all companies listed on US exchanges.
• The level of detail provided, including weighted average prices for each tranche of sales, is consistent with best practices for transparency.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they represent a small portion of the total outstanding shares.
• The transactions provide transparency into executive compensation and trading activities.

Key Dates

Keywords

TransDigm Group, Joel Reiss, stock options, share sales, SEC Form 4, insider trading, executive compensation